Related by context. All words. (Click for frequent words.) 74 lobular carcinoma 72 urothelial carcinoma 72 precursor lesions 71 epithelial ovarian cancer 71 ductal carcinomas 71 epithelial tumors 71 grade cervical intraepithelial 70 prostate carcinoma 70 pancreatic adenocarcinoma 70 HGPIN 70 gastric adenocarcinoma 70 epithelial ovarian 70 prostate cancer CaP 69 breast carcinoma 69 ovarian carcinoma 69 adenomatous polyps 69 invasive carcinoma 69 cervical intraepithelial neoplasia 69 situ LCIS 69 ADPKD 69 CIN3 69 curative resection 69 histological subtype 69 node metastases 69 situ CIS 69 advanced adenoma 69 CIN2 + 68 GISTs 68 basal cell carcinoma BCC 68 PCa 68 histologic subtype 68 squamous cell carcinoma SCC 68 breast carcinomas 68 neoplasia 68 Hurthle cell 68 neoplasias 68 Papillary 68 peritoneal carcinomatosis 68 metastatic gastric 68 intraepithelial neoplasia 68 papillary renal cell carcinoma 67 histologically confirmed 67 renal cell carcinomas 67 prostate adenocarcinoma 67 colorectal carcinoma 67 ASCUS 67 squamous intraepithelial lesions 67 Squamous 67 hematopoietic cancers 67 urine cytology 67 nonmelanoma skin cancers 67 Metastatic breast cancer 67 Adenomas 67 endometrial hyperplasia 67 pheochromocytoma 67 renal tumors 67 neoplasm 67 Sezary syndrome 67 pelvic lymphadenectomy 67 Acute myeloid leukemia 67 endometrial cancers 67 SLNB 67 acute GvHD 67 atypical hyperplasia 67 metastatic bladder 67 paragangliomas 67 hamartomas 67 total thyroidectomy 67 gastric carcinoma 66 neoadjuvant therapy 66 hepatocellular carcinomas 66 Hepatocellular Carcinoma HCC 66 Adjuvant chemotherapy 66 HNSCC 66 bladder carcinoma 66 leiomyomas 66 precancerous cervical lesions 66 metastatic malignant melanoma 66 colorectal adenoma 66 cervical lesions 66 distant metastasis 66 axillary dissection 66 mucinous 66 metachronous 66 myeloproliferative diseases 66 liver metastasis 66 operable breast cancer 66 malignant neoplasm 66 pulmonary metastases 66 locoregional 66 grade cervical dysplasia 66 axillary lymph node 66 ErbB2 positive 66 radioiodine therapy 66 squamous 66 HER2 overexpression 66 Immunohistochemical staining 66 nonsmall cell lung cancer 66 nonmetastatic 66 hepatocellular carcinoma HCC 66 stage IIIB 66 squamous cell lung cancer 66 prostate cancer PCa 66 colorectal adenocarcinoma 66 resectable 66 metastatic prostate 66 lymph node dissection 66 choriocarcinoma 66 ductal breast cancer 66 bronchogenic carcinoma 66 metastatic malignant 66 CYT# potent vascular disrupting 66 urothelial cancer 66 prostate carcinomas 66 differentiated thyroid 65 nephrogenic 65 neoplasms 65 cervical lymph nodes 65 lymphocytosis 65 endometrial carcinoma 65 micrometastasis 65 leukemia AML 65 malignant pleural mesothelioma 65 biochemical relapse 65 pancreatic lung 65 cholangiocarcinoma 65 metastatic colorectal 65 astrocytomas 65 skeletal metastases 65 colorectal neoplasms 65 recurrent NSCLC 65 fallopian tube carcinoma 65 metastatic neuroendocrine tumors 65 gastrointestinal stromal tumors GISTs 65 pT3 65 distant metastases 65 chlamydial infection 65 bone metastasis 65 B Cell Lymphoma 65 T1a 65 Ductal carcinoma 65 Anaplastic 65 IV NSCLC 65 bladder tumors 65 lymphadenectomy 65 recurrent metastatic 65 metastatic RCC 65 Lymph node 65 gastrointestinal stromal tumor 65 papillary carcinoma 65 cutaneous squamous cell carcinoma 65 dysplastic lesions 65 tumorigenicity 65 colorectal cancer CRC 65 breast endometrial 65 nodal metastasis 65 histopathologic examination 65 diabetes mellitus DM 65 cutaneous melanoma 65 cytoreduction 65 HBeAg negative 65 adjuvant radiotherapy 65 hepatorenal syndrome 65 immunohistochemical staining 65 grade squamous intraepithelial 64 intravesical therapy 64 tumors GIST 64 completely resected 64 androgen receptor AR 64 polycythemia vera PV 64 cervical dysplasia 64 BCG refractory 64 metastatic lymph nodes 64 neoadjuvant treatment 64 hematologic disorders 64 pre cancerous lesion 64 systemic amyloidosis 64 metastatic lung cancer 64 thyroglobulin 64 bladder cancers 64 CMV disease 64 myeloproliferative neoplasms 64 pT2 64 pleural mesothelioma 64 acute myeloid 64 MALT lymphoma 64 Basal cell 64 PCNSL 64 EUS FNA 64 advanced neoplasia 64 acute leukemias 64 NMIBC 64 thymoma 64 depsipeptide 64 malignant neoplasms 64 intestinal metaplasia 64 recurrent ovarian 64 K ras mutations 64 micrometastases 64 papillary thyroid carcinoma 64 seminoma 64 lung pancreatic 64 Acute Myeloid Leukaemia AML 64 sarcomatoid 64 neoplastic 64 Mitomycin C 64 lymph node metastases 64 advanced adenomas 64 precancerous cervical 64 cytologic 64 thromboembolic disease 64 peritoneal cancer 64 etiologic agent 64 osteosarcomas 64 non squamous NSCLC 64 CP CPPS 64 myelofibrosis polycythemia vera 64 HSCT 64 mycosis fungoides 64 HBsAg 64 malignant polyps 64 castration resistant 64 monoclonal gammopathy 64 latent tuberculosis TB 64 Carcinoma 64 precancerous condition 64 ano genital warts 64 Lymphocytic 64 polyp recurrence 64 carcinoids 64 surgically resectable 64 cytoreductive nephrectomy 64 ductal lobular 64 #F FDG PET 64 extranodal 64 CIN2 64 AAT deficiency 64 superficial basal cell carcinoma 64 clinically localized prostate 64 Leydig cell 64 Chronic pancreatitis 64 relapsed MM 64 FDG PET imaging 64 unresectable tumors 64 Polycythemia vera 64 invasive ductal 64 neovascularisation 64 IgA antibodies 64 #.#ng/ml 64 chemoradiotherapy 64 basal cell nevus syndrome 64 castrate resistant 64 premalignant lesion 64 malignant lymphoma 64 paraganglioma 64 Circulating tumor cells 64 ductal cancer 64 T1c 64 lymph node metastasis 63 HBV infections 63 solar keratosis 63 axillary lymph nodes 63 abnormal cytology 63 receptor tyrosine kinase inhibitor 63 Chronic lymphocytic leukemia 63 recurrent glioblastoma multiforme 63 squamous cell cancers 63 myeloproliferative disorder 63 latent tuberculosis infection 63 Leukemias 63 MGUS 63 premalignant 63 LHRH receptor positive 63 nasopharyngeal carcinoma 63 ovarian malignancy 63 pathologic diagnosis 63 renal carcinoma 63 hyperplastic 63 LTBI 63 atypia 63 specific antigen PSA 63 TIMP 63 neutropaenia 63 ependymoma 63 severe oral mucositis 63 Radical prostatectomy 63 metastatic pancreatic 63 adenoma 63 CTAP# Capsules 63 neuroendocrine cancers 63 follicular thyroid cancer 63 R0 resection 63 catheter angiography 63 haematologic 63 neuroendocrine carcinoma 63 colorectal liver metastases 63 Heavy menstrual bleeding 63 haematopoietic 63 p# biomarker 63 Epstein Barr virus EBV 63 DCIS ductal carcinoma 63 diagnostic modality 63 transitional cell carcinoma 63 myelomas 63 HER2 expression 63 chemoresistant 63 atrophic gastritis 63 serous ovarian cancer 63 Sentinel node biopsy 63 endometrioid 63 CMV infection 63 endocrine therapies 63 Waldenstrom macroglobulinemia 63 tumor histology 63 deCODE BreastCancer 63 NPM1 mutation 63 metastatic GIST 63 hepatocellular carcinoma 63 PAOD 63 prognostic variables 63 smoldering myeloma 63 oligodendrogliomas 63 biliary stones 63 thyroid nodules 63 vaginal lesions 63 carcinoid tumors 63 pre malignant lesions 63 BRCA mutation carriers 63 urothelial bladder cancer 63 stage IIIA 63 carcinoma HCC 63 solar keratoses 63 gastric cancers 63 C. trachomatis 63 BRCA1 mutation carriers 63 myeloproliferative disorders 63 breast pancreatic 63 malignant fibrous histiocytoma 63 situ DCIS 63 anaplastic 63 lung carcinomas 63 transgene expression 63 sPLA2 63 fallopian tube cancers 63 refractory ovarian cancer 63 carcinoid tumor 63 pituitary adenomas 63 intraductal 63 Endometrial 63 syngeneic 63 proctitis 63 Medullary thyroid cancer 62 Pseudomonas aeruginosa infections 62 EBRT 62 fibroadenomas 62 PNET 62 intestinal polyps 62 surgically resected 62 protein tyrosine phosphatase 62 atypical ductal hyperplasia 62 metaplasia 62 geographic atrophy 62 pancreatic prostate 62 pediatric malignancies 62 cardiac troponin T 62 prognostic indicator 62 invasive carcinomas 62 androgen independent 62 pancreatic carcinoma 62 Prognostic factors 62 Advanced Renal Cell 62 Candida infection 62 primary hyperparathyroidism 62 diffuse gastric 62 HbF 62 simplex virus 62 hormone refractory 62 AA Amyloidosis 62 adenocarcinomas 62 malignant transformation 62 essential thrombocythemia 62 cancerous cervical lesions 62 neoplastic lesions 62 pelvic malignancies 62 histologies 62 HER2 positive cancers 62 progesterone receptor negative 62 adnexal mass 62 serum biomarker 62 hepatic metastases 62 Akt activation 62 Metastatic colorectal cancer 62 curative therapy 62 bacteriuria 62 malignant pancreatic 62 kidney urologic 62 prostate pancreatic 62 stratifying patients 62 invasive lobular carcinoma 62 Adenocarcinoma 62 deCODE ProstateCancer TM 62 CTEPH 62 relapsed SCLC 62 lymphomas leukemias 62 cranial irradiation 62 idiopathic myelofibrosis 62 nonproliferative 62 papillary 62 pathologic examination 62 oral squamous cell 62 Surgical resection 62 Gorlin syndrome 62 renal biopsy 62 tumor recurrence 62 BRCA deficient 62 thymectomy 62 ovarian breast 62 systemic scleroderma 62 mesotheliomas 62 chromosomal aberrations 62 ABL1 62 breast uterine 62 BRAF V#E 62 carcinomas 62 serologic testing 62 sCJD 62 nodal metastases 62 vWD 62 postoperative morbidity 62 herpes zoster shingles 62 localized renal 62 anti angiogenic therapy 62 uterine tumors 62 graft dysfunction 62 leukemia ALL 62 pleomorphic 62 B7 H3 62 chemoradiation therapy 62 radical nephrectomy 62 malignant prostate 62 Ductal Carcinoma 62 malignancy 62 cisplatin resistant 62 HER2 positivity 62 esophageal carcinoma 62 clinically detectable 62 LHRH agonists 62 embryonal rhabdomyosarcoma 62 premalignant lesions 62 preoperative chemotherapy 62 dasatinib Sprycel ® 62 endometrial adenocarcinoma 62 histopathologic 62 lymph node involvement 62 SSc 62 Follicular Lymphoma 62 mRCC 62 underwent surgical resection 62 acute humoral rejection 62 Glioblastoma Multiforme 62 fine needle aspiration 62 malignant ovarian 62 Surgical excision 62 malignant growths 62 microsatellite instability 62 Glioma 62 unresectable 62 metastatic HER2 positive 62 penile cancers 62 System IPSS 62 choroidal neovascularization 62 gastric cardia 62 antiangiogenic agent 62 thoracoscopic lobectomy 62 pancreatic islet cell 62 neuroendocrine tumors 62 gadolinium enhanced 62 urine dipstick 62 metastatic basal cell 62 Neisseria gonorrhoeae 62 MGd 62 nonmelanoma skin cancer 62 chlamydial 62 pleural fluid 62 chemosensitivity 62 metastatic renal cell carcinoma 62 microscopic hematuria 62 Systemic lupus erythematosus 62 BRCA2 mutation carriers 62 malignant cancerous 62 multigene expression test 62 esophageal cancers 62 cell acute lymphoblastic 62 HER2 positive metastatic breast 62 carcinoid 62 parathyroid carcinoma 62 membranous nephropathy 62 carcinoma 62 LRP5 62 non metastatic osteosarcoma 62 tumoral 62 gefitinib Iressa 62 alveolar rhabdomyosarcoma 62 Xanafide 62 metastatic carcinoma 62 leiomyoma 62 LVNC 62 cytological 62 colorectal gastric 61 adenomatous 61 clinico pathological 61 Li Fraumeni Syndrome 61 erlotinib Tarceva ® 61 superficial basal cell carcinomas 61 supratentorial 61 liver metastases 61 resistant hormone refractory 61 transplantation HCT 61 cervical adenocarcinoma 61 prostate ovarian 61 medullary thyroid cancer 61 colorectal adenomas 61 cisplatin chemotherapy 61 locoregional recurrence 61 Hodgkin lymphoma HL 61 Immunohistochemical analysis 61 BRAF V#E mutation 61 moderately emetogenic 61 follicular adenoma 61 metastatic renal 61 immunohistochemical analysis 61 esophagogastric junction 61 underwent radical prostatectomy 61 chronic GVHD 61 gastrointestinal stromal tumor GIST 61 polycythemia vera essential thrombocythemia 61 pancreatic ovarian 61 hepatoma 61 Immunohistochemistry 61 metastatic adenocarcinoma 61 lymphovascular invasion 61 hypervascular tumors 61 lymphatic mapping 61 BCG refractory carcinoma 61 Monocyte 61 lobular carcinomas 61 nodal dissection 61 Venous thromboembolism 61 metastatic lesion 61 cell carcinoma 61 urothelial 61 aminotransferase 61 anal intraepithelial neoplasia 61 tumor xenograft models 61 Ribavirin causes 61 colon rectal cancer 61 benign neoplasms 61 Gliomas 61 biliary tract cancer 61 invasive ductal carcinoma 61 PSADT 61 lymphocytic 61 multiple myeloma MM 61 PSA nadir 61 pheochromocytomas 61 histologic findings 61 renal allograft 61 DCIS lesions 61 myelodysplastic syndrome MDS 61 bacterial prostatitis 61 macroalbuminuria 61 Endometrial cancer 61 biochemical recurrence 61 ara C 61 sonographically guided 61 thyroid dysfunction 61 candidemia 61 bone scintigraphy 61 lung adenocarcinomas 61 lymphatic tissue 61 parathyroid 61 invasive ductal breast cancer 61 grade gliomas 61 Candida infections 61 leucopenia 61 fibrosarcoma 61 ovarian pancreatic 61 liver resection 61 superficial bladder cancer 61 chromosomal mutations 61 EBUS FNA 61 recurrent glioblastoma 61 gynecologic malignancy 61 immunohistochemical 61 cytologically confirmed 61 gastrointestinal cancers 61 EXJADE 61 choroidal neovascularization CNV 61 postoperative chemotherapy 61 Bezielle 61 postoperative pulmonary 61 IPAH 61 HER2 negative 61 gastrointestinal malignancies 61 HER2 receptor 61 bladder ovarian 61 chronic granulomatous disease 61 allogeneic bone marrow 61 allogenic 61 hypercalcemia 61 ALK mutations 61 FluCAM arm 61 pulmonary resection 61 CIN3 + 61 adrenocortical cancer 61 severe neutropenia 61 Trichomonas vaginalis 61 Cardiotoxicity 61 Toxicities 61 Fas ligand 61 mediastinal lymph nodes 61 adrenalectomy 61 gastrointestinal stromal tumors 61 pancreatic colon 61 mutated K ras 61 preoperative staging 61 FDG uptake 61 sentinel lymph node biopsy 61 complement inhibitor eculizumab 61 Sjögren syndrome 61 vWF 61 Glioblastoma multiforme GBM 61 infiltrating ductal carcinoma 61 lymphadenopathy 61 prognostic indicators 61 grade dysplasia 61 ductal adenocarcinoma 61 androgen ablation 61 squamous carcinoma 61 lung resection 61 etiologic 61 esophageal squamous cell carcinoma 61 T2DM 61 immunoblotting 61 gastroesophageal junction 61 pDC 61 Accelerated Partial Breast Irradiation 61 thyroid carcinoma 61 inducible nitric oxide synthase 61 cystectomy 61 metastatic ovarian cancer 61 refractory prostate cancer 61 thrombotic complications 61 relapsed Acute Myeloid 61 testicular cancers 61 gastrointestinal stromal tumors GIST 61 adenoma recurrence 61 MYCN amplification 61 nonalcoholic steatohepatitis NASH 61 Rectal cancer 61 isoenzyme 61 squamous cell 61 epithelial cancers 61 SHPT 61 Androgen deprivation therapy 61 Myelofibrosis 61 F FLT 61 para aortic 61 anterior uveitis 61 malignant ascites 61 radiotherapy RT 61 allogeneic hematopoietic stem cell 61 colorectal cancer liver metastases 61 mediastinitis 61 serum prostate 61 extracapsular extension 61 aneuploidies 61 ovarian tumors 61 prognostic marker 61 Wilms tumors 61 Vidofludimus 61 diagnostic biomarker 61 intracranial hemorrhage ICH 61 EGFR mutation positive 61 seropositivity 61 IgA deficiency 61 endocervical 61 transthyretin amyloidosis 61 clonogenic 61 soft tissue sarcomas 61 onset diabetes mellitus 61 immunocompetent 61 Langerhans cell histiocytosis 61 lymphoma subtypes 61 androgen deprivation 61 lung metastasis 61 Radiofrequency ablation 61 angiosarcoma 61 Glioblastoma Multiforme GBM 61 TRUS biopsy 61 BRCA1 BRCA2 61 renal scarring 61 benign prostatic hyperplasia enlarged 61 anal cancers 61 TKI therapy 61 GnRH agonists 61 hypertrophic scars 61 Metastases 61 external genital lesions 61 precancerous tumors 61 Hurler syndrome 61 HNPCC 61 recurrent bladder 61 advanced hepatocellular carcinoma 61 allogeneic HSCT 61 testicular germ cell 61 eosinophilic pneumonia 61 Hashimoto thyroiditis 60 LV dysfunction 60 liposomal amphotericin B 60 fetal malformations 60 antiangiogenic therapy 60 acute promyelocytic leukemia 60 GSTP1 60 invasive aspergillosis 60 N. gonorrhoeae 60 LungAlert TM 60 Cholangiocarcinoma 60 MAGE A3 ASCI 60 pediatric acute lymphoblastic 60 metastatic lesions 60 CaP 60 cervical cancer precancerous 60 cervical vaginal 60 mesangial 60 GSTT1 60 benign noncancerous 60 interleukin IL -# 60 refractory colorectal cancer 60 primary peritoneal 60 Severe Primary IGFD 60 malignant lesions 60 chemoembolization 60 interferon γ 60 lung esophageal 60 SUVmax 60 transvaginal sonography 60 leiomyosarcoma 60 nodular 60 STRIDE PD 60 laparoscopically assisted 60 HIV HCV coinfected 60 virotherapy 60 germline mutations 60 guaiac 60 Malignant Melanoma 60 HBV infection 60 ductal 60 hyperparathyroidism 60 lymph node enlargement 60 refractory metastatic 60 neoadjuvant chemotherapy 60 GVAX Pancreas Vaccine 60 Actinic Keratosis 60 Prostate specific antigen 60 dysplasias 60 indolent lymphomas 60 Adjuvant therapy 60 hormone receptor negative 60 transfusion syndrome 60 benign prostatic hypertrophy BPH 60 enteroviral infection 60 essential thrombocythemia ET 60 FLT3 60 abnormal Pap smears 60 Chlamydia trachomatis infection 60 hormonally sensitive 60 Myelodysplastic Syndrome 60 radiochemotherapy 60 Liver transplantation 60 p# mutations 60 urolithiasis 60 dysplastic lesions caused 60 castrate resistant prostate cancer 60 poorer prognosis 60 hepatocellular 60 pain palliation 60 debulking surgery 60 multisystem disease 60 Eisenmenger syndrome 60 ADAMTS# 60 AGHD 60 HPV subtypes 60 efalizumab 60 multimodality therapy 60 nutlin 3a 60 angiographically 60 CLL SLL 60 seminomas 60 bowel cancers 60 endoscopic resection 60 peritumoral brain edema 60 cell adhesion molecule 60 histone deacetylase inhibitor 60 lenalidomide Revlimid R 60 endometriosis ovarian cysts 60 oesophageal adenocarcinoma 60 malignant nodules 60 LPS induced 60 ER CHOP 60 Postoperative complications 60 Vicinium TM 60 Colorectal cancers 60 TNF antagonist 60 cervical lymph node 60 follicular lymphoma FL 60 vulvar intraepithelial neoplasia 60 Cutaneous T 60 EGFR HER2 60 prognostic factor 60 leukaemic stem cells 60 medically inoperable 60 immunodeficiency disorders 60 hepatocellular cancer 60 tumor hypoxia 60 ALND 60 untreated celiac disease 60 autologous hematopoietic stem cell 60 Bayer HealthCare Onyx Pharmaceuticals 60 metastatic liver 60 immune dysregulation 60 trophoblast cells 60 % CI #.#-#.# [005] 60 Chronic Myelogenous Leukemia CML 60 TPMT 60 mammographically 60 Estrogen Receptor 60 chronic thromboembolic pulmonary 60 arterial calcification 60 colorectal pancreatic 60 hyperoxaluria 60 trabectedin 60 dysplastic nevi 60 immunosuppressive regimens 60 microsphere therapy 60 intravesical infusion therapy 60 gastrointestinal GI cancers 60 grade glioma 60 adjuvant radiation 60 Non Alcoholic Steatohepatitis 60 smoldering multiple myeloma 60 allograft rejection 60 immunopathology 60 epithelioid 60 tryptase 60 hypereosinophilic syndrome 60 deCODE BreastCancer TM 60 colorectal cancers 60 cervical breast 60 vinca alkaloids 60 localized prostate 60 adjuvant therapy 60 venous blood clots 60 extracolonic findings 60 chronic periodontitis 60 ABCB1 60 preoperative PSA 60 invasive candidiasis 60 excisional biopsy 60 uterine cervix 60 radiosensitivity 60 H. pylori eradication 60 neovascular 60 subclinical 60 hypovitaminosis D 60 Critical Limb Ischemia CLI 60 idiopathic PAH 60 DFMO 60 tuberous sclerosis TS 60 F FDG PET 60 Gleevec resistant 60 mutational status 60 transgenic rats 60 colorectal tumors 60 erythema nodosum 60 elevated LDH 60 lobular cancer 60 cardiac troponin 60 somatic mutations 60 extracranial 60 Chronic HCV 60 SGPT 60 histologic 60 cytoreductive surgery 60 contralateral breast 60 oral Hycamtin 60 coronary stenosis 60 node dissection 60 abnormal pap smears 60 Vorinostat 60 relapsed ovarian cancer 60 NMP# 60 benign nodules 60 amenorrhoea 60 glomerulonephritis 60 monogenic 60 intact parathyroid hormone 60 Cytogenetic 60 International Prognostic Scoring 60 pleurodesis 60 anaplastic astrocytoma 60 hepatocellular carcinoma liver 60 tuberculin skin testing 60 hydronephrosis 60 MTT assay 60 nonmelanoma 60 chromosomal rearrangement 60 SCCHN 60 obstructive coronary 60 neutropenic patients 60 metastatic prostate cancer 60 androgen dependent 60 testicular tumors 60 benign breast 60 Epstein Barr Virus EBV 60 sputum cytology 60 thyrotropin 60 Polymorphisms 60 serum phosphate 60 radical cystectomy 60 taxane therapy 60 malignant pleural mesothelioma MPM 60 cytotoxic chemotherapy 60 antitumor effect 60 ALA PDT 60 vaginal hysterectomy 60 RhD negative 60 FDG-PET/CT 60 undergoing radical prostatectomy 60 histologically proven 60 GH deficiency 60 mouse xenograft models 60 stem cell engraftment 60 stem cells CSCs 60 renal cysts 60 pretransplant 60 leukaemias 60 clinicopathologic 60 breast lesions 60 IGFBP 60 LSIL 60 molecular abnormalities 60 T1DM 60 uterine ovarian 60 Barrett esophagus BE 60 acute lymphoid leukemia 60 liver colon rectal 60 busulfan 60 CYP #D# 60 endometrial biopsy 60 MTHFR 60 Renal Cell Carcinoma RCC 60 Tumor shrinkage 60 haematological cancers 60 ERalpha 60 pulmonary metastasis 60 astrocytoma 60 postoperative complication 60 pancreatic NET 60 mCRC patients 60 spinal metastases 60 gastroduodenal 60 stage IIIb IV 60 psoriatic arthritis PsA 60 AA amyloidosis 60 artery stenosis 60 invasive cervical cancer 60 keratoses 60 lung biopsy 60 leukemia APL 60 precancer 60 Legg Calvé Perthes disease 60 Diabetic nephropathy 60 Squamous Cell 60 maternal serum 60 percutaneous biopsy 60 Aplidin 60 corticosteroid therapy 60 refractory acute myeloid 60 pancytopenia 59 RECIST Response Evaluation Criteria 59 Haptoglobin 59 haematopoietic stem cell 59 lactate dehydrogenase 59 advanced epithelial ovarian 59 eribulin mesylate 59 hematuria 59 CC genotype 59 FOLFOX6